Jhun, Byung Woo Professor

Pulmonary and Critical Care Medicine

Jhun, Byung Woo

Appointment

Clinical Assistant Professor

Speciality Interests

Schedule

schedule of week
05 MON
05
TUE
06
WEN
07
THU
08
FRI
09
AM available
PM

Medical School

2018 Ph.D. in Medicine Sungkyunkwan University School of Medicine, Korea 2015 Master of Science Sungkyunkwan University School of Medicine, Korea 2007 Pusan National University School of Medicine, Korea

Specialty Training

Specialty Training
Fellowship   2016~2016 Division of Pulmonology, Seoul National University Hospital, Korea
2012~2013 Division of Pulmonology, Seoul National University Hospital, Korea
Residency   2008~2012 Department of Medicine, Seoul National University Hospital, Korea
Internship   2007~208 Seoul National University Hospital, Korea

Other Education

  • 2018~Present Staff Division of Pulmonary and critical care medicine, Samsung Medical Center
    2022~Present Associate Professor Department of Medicine, Sungkyunkwan University School of Medicine
    2019~2022 Assistant Professor Division of Pulmonary and critical care medicine, Samsung Medical Center
    2018~2019 Clinical Instructor Division of Pulmonary and critical care medicine, Samsung Medical Center
    2016~2017 Clinical Instructor Division of Pulmonary, Allergy & Critical Care Medicine, Hallym University Kangnam Sacred Heart Hospital

Thesis

  • ANTIMICROB AGENTS CH 2024 10.1128/aac.01055-24 Long-term clinical course of Mycobacterium avium complex pulmonary disease patients with treatment failure Zo, S; Choe, J; Kim, DH; Kim, SY; Jhun, BW
    View PubMed
  • SCI REP-UK 2024 10.1038/s41598-024-66523-x Single-cell transcriptomics by clinical course of Mycobacterium avium complex pulmonary disease Kim, SY; Zo, S; Kim, DH; Shin, SJ; Jhun, BW
    View PubMed
  • OPEN FORUM INFECT DI 2024 10.1093/ofid/ofae345 Long-term Outcomes of Adjunctive Lung Resection for Nontuberculous Mycobacteria Pulmonary Disease Kang, N; Jhun, BW
    View PubMed
  • EBIOMEDICINE 2024 10.1016/j.ebiom.2024.105198 Protein-energy restriction-induced lipid metabolism disruption causes stable-to-progressive disease shift in Mycobacterium avium-infected female mice Choi, S; Lee, JM; Kim, KES; Park, JH; Kim, LH; Park, J; Jeon, Y; Jhun, BW; Kim, SY; Hong, JJ; Shin, SJ
    View PubMed
  • BMC MICROBIOL 2024 10.1186/s12866-024-03308-2 Comparison of the sputum microbiome between patients with stable nontuberculous mycobacterial pulmonary disease and patients requiring treatment Song, MJ; Kim, DH; Kim, SY; Kang, N; Jhun, BW
    View PubMed
  • J CLIN MED 2024 10.3390/jcm13102941 QMAC-DST for Rapid Detection of Drug Resistance in Pulmonary Tuberculosis Patients: A Multicenter Pre-Post Comparative Study Kwak, N; Lee, SY; Kim, S; Song, EB; Yim, JJ; Shim, TS; Jeon, D; Jhun, BW; Seok, KH; Kim, S; Kwon, S; Mok, J
    View PubMed
  • J CLIN IMMUNOL 2024 10.1007/s10875-024-01687-9 Ruxolitinib Improves Immune-Dysregulation Features but not Epigenetic Abnormality in a Patient with STAT1 GOF Koh, JY; Kim, DR; Son, S; Park, H; Kim, KR; Min, SW; Lee, HS; Jhun, BW; Kang, ES; Jung, IKY; Kang, JM; Kim, YJ; Shin, EC
    View PubMed
  • CLIN INFECT DIS 2024 10.1093/cid/ciae131 Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort Kwak, N; Henkle, E; Hwang, H; Jeon, D; Jhun, BW; Jo, KW; Kang, YA; Kim, HJ; Kim, JY; Kim, YR; Kwon, YS; Lee, JH; Mok, J; Park, Y; Shim, TS; Sohn, H; Whang, J; Yim, JJ
    View PubMed
  • SCI TRANSL MED 2024 10.1126/scitranslmed.adi7558 An anti-mycobacterial conjugated oligoelectrolyte effective against Mycobacterium abscessus Zhang, KX; Limwongyut, J; Moreland, AS; Wei, SCJ; Min, TJJ; Sun, Y; Shin, SJ; Kim, SY; Jhun, BW; Pethe, K; Bazan, GC
    View PubMed
  • CHEST 2024 10.1016/j.chest.2023.08.025 Outcomes of Intermittent Multidrug IV Therapy for Refractory Mycobacterium abscessus Pulmonary Disease Im, Y; Kim, SY; Kim, DH; Jhun, BW
    View PubMed
  • ANN LAB MED 2024 10.3343/alm.2024.44.1.92 In Vitro Activity of Benzimidazole (SPR719) Against Clinical Isolates of Nontuberculous Mycobacteria With and Without Clarithromycin or Amikacin Resistance Kim, DH; Zo, S; Kim, SY; Jhun, BW
    View PubMed
  • J CLIN MED 2023 10.3390/jcm12247751 The Clinical Implications of Serum Carbohydrate Antigen 19-9 Levels in Patients with Nontuberculous Mycobacteria Pulmonary Disease Lee, DG; Jhun, BW
    View PubMed
  • J INFECT DIS 2023 10.1093/infdis/jiad591 Oral β-Lactam Pairs for the Treatment of Mycobacterium avium Complex Pulmonary Disease Negatu, DA; Shin, SJ; Kim, SY; Jhun, BW; Dartois, V; Dick, T
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-48001-y Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection Lee, JM; Kim, LH; Kim, SY; Jhun, BW; Lee, W; Shin, SJ
    View PubMed
  • J CLIN MED 2023 10.3390/jcm12227125 Spontaneous Cultural Conversion Rate of Mycobacterium avium Complex Pulmonary Disease Based on BACES Severity Kim, BG; Yu, JY; Jhun, BW
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-47230-5 Changes in sputum microbiota during treatment for nontuberculous mycobacterial pulmonary disease Kim, BG; Yu, JY; Kim, SY; Kim, DH; Jhun, BW
    View PubMed
  • CLIN LAB 2023 10.7754/Clin.Lab.2022.221115 Performance Evaluation of MolecuTech REBA Myco-ID Using HybREAD480 for Identification of Nontuberculous Mycobacteria Kim, JA; Yu, HJ; Hwang, YY; Kang, OK; Shim, HJ; Jhun, BW; Lee, NY; Kim, TY; Huh, HJ
    View PubMed
  • MICROBIOL SPECTR 2023 10.1128/spectrum.02051-23 Clinical Characteristics and Treatment Outcomes of Mycobacterium fortuitum Pulmonary Disease Kim, SR; Yu, JY; Kim, SY; Kim, DH; Jhun, BW
    View PubMed
  • PLOS ONE 2023 10.1371/journal.pone.0285143 The lung microbiota in nontuberculous mycobacterial pulmonary disease Kim, BG; Kang, N; Kim, SY; Kim, DH; Kim, H; Kwon, OJ; Huh, HJ; Lee, NY; Jhun, BW
    View PubMed
  • J CLIN MICROBIOL 2023 10.1128/jcm.01086-22 Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration Yu, HJ; Kim, TY; Kim, G; Shim, HJ; Kang, OK; Kim, S; Kim, CK; Jhun, BW; Lee, NY; Huh, HJ; Lee, HJ
    View PubMed
  • GUT MICROBES 2022 10.1080/19490976.2022.2073132 Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection Kim, YJ; Lee, JY; Lee, JJ; Jeon, SM; Silwal, P; Kim, IS; Kim, HJ; Park, CR; Chung, C; Han, JE; Choi, JW; Tak, EJ; Yoo, JH; Jeong, SW; Kim, DY; Ketphan, W; Kim, SY; Jhun, BW; Whang, J; Kim, JM; Eoh, H; Bae, JW; Jo, EK
    View PubMed
  • LANCET 2022 9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea Mok, J; Lee, M; Kim, DK; Kim, JS; Jhun, BW; Jo, KW; Jeon, D; Lee, T; Lee, JY; Park, JS; Lee, SH; Kang, YA; Lee, JK; Kwak, N; Ahn, JH; Shim, TS; Kim, SY; Kim, S; Kim, K; Seok, KH; Yoon, S; Kim, YR; Kim, J; Yim, D; Hahn, S; Cho, SN; Yim, JJ
    View PubMed
  • ANTIMICROB AGENTS CH 2022 10.1128/aac.00774-22 Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease Kim, SR; Jang, M; Kim, SY; Kim, DH; Jhun, BW
    View PubMed
  • J INFECT CHEMOTHER 2022 10.1016/j.jiac.2022.03.026 Treatment outcome of continuation of intravenous amikacin for Mycobacterium abscessus pulmonary disease with a persistent culture positivity after the treatment initiation Park, YE; Park, SY; Jhun, BW; Park, Y; Kang, YA; Park, J; Kwak, N; Yim, JJ; Shim, TS; Jo, KW
    View PubMed
  • MICROBIOL SPECTR 2022 10.1128/spectrum.01088-22 Antibiotic Maintenance and Redevelopment of Nontuberculous Mycobacteria Pulmonary Disease after Treatment of Mycobacterium avium Complex Pulmonary Disease Zo, S; Kim, H; Kwon, OJ; Jhun, BW
    View PubMed
  • J KOREAN MED SCI 2022 10.3346/jkms.2022.37.e250 The Higher Incidence of COVID-19 in Patients With Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea Kim, SH; Jhun, BW; Jeong, BH; Park, HY; Kim, HJ; Kwon, OJ; Shin, SH
    View PubMed
  • THORAC CANCER 2022 10.1111/1759-7714.14587 Clinical utility of EBUS-TBNA of hilar, interlobar, and lobar lymph nodes in patients with primary lung cancer Wi, S; Kim, BG; Shin, SH; Jhun, BW; Yoo, H; Jeong, BH; Lee, K; Kim, H; Kwon, OJ; Han, J; Kim, J; Um, SW
    View PubMed
  • CHEST 2022 10.1016/j.chest.2021.10.048 Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality Im, Y; Hwang, NY; Kim, K; Kim, H; Kwon, OJ; Jhun, BW
    View PubMed
  • ANTIMICROB AGENTS CH 2022 10.1128/aac.02027-21 Relationship between Resistance to Ethambutol and Rifampin and Clinical Outcomes in Mycobacterium avium Complex Pulmonary Disease Moon, SM; Kim, SY; Kim, DH; Huh, HJ; Lee, NY; Jhun, BW
    View PubMed
  • SCI REP-UK 2022 10.1038/s41598-022-06022-z Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity Kim, BG; Jhun, BW; Kim, H; Kwon, OJ
    View PubMed
  • J CLIN MED 2021 10.3390/jcm10194581 In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease Kim, DH; Kim, BG; Kim, SY; Huh, HJ; Lee, NY; Koh, WJ; Kim, H; Kwon, OJ; Jhun, BW
    View PubMed
  • J INFECTION 2021 10.1016/j.jinf.2021.07.030 Impact of treatment duration on recurrence of chronic pulmonary aspergillosis Im, Y; Jhun, BW; Kang, ES; Koh, WJ; Jeon, K
    View PubMed
  • LUNG CANCER 2021 10.1016/j.lungcan.2021.08.016 Infectious complications of EBUS-TBNA: A nested case-control study using 10-year registry data Kang, N; Shin, SH; Yoo, H; Jhun, BW; Lee, K; Um, SW; Kim, H; Jeong, BH
    View PubMed
  • EUR RESPIR J 2021 10.1183/13993003.02269-2019 Genome-wide association study in patients with pulmonary Mycobacterium avium complex disease Namkoong, H; Omae, Y; Asakura, T; Ishii, M; Suzuki, S; Morimoto, K; Kawai, Y; Emoto, K; Oler, AJ; Szymanski, EP; Yoshida, M; Matsuda, S; Yagi, K; Hase, I; Nishimura, T; Sasaki, Y; Asami, T; Shiomi, T; Matsubara, H; Shimada, H; Hamamoto, J; Jhun, BW; Kim, SY; Huh, HJ; Won, HH; Ato, M; Kosaki, K; Betsuyaku, T; Fukunaga, K; Kurashima, A; Tettelin, H; Yanai, H; Mahasirimongkol, S; Olivier, KN; Hoshino, Y; Koh, WJ; Holland, SM; Tokunaga, K; Hasegawa, N
    View PubMed
  • CHEST 2021 10.1016/j.chest.2021.02.025 Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease Kang, N; Jeon, K; Kim, H; Kwon, OJ; Huh, HJ; Lee, NY; Daley, CL; Koh, WJ; Jhun, BW
    View PubMed
  • CLIN INFECT DIS 2021 10.1093/cid/ciaa1361 Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey van Ingen, J; Aliberti, S; Andrejak, C; Chalmers, JD; Codecasa, LR; Daley, CL; Hasegawa, N; Griffith, DE; Hoefsloot, W; Huitt, G; Jarand, J; Jhun, BW; Loebinger, MR; Marras, TK; Morimoto, K; Polverino, E; Ringshausen, FC; Santin, M; Thomson, R; Wagner, D; Wallace, RJ; Winthrop, KL; Yim, JJ
    View PubMed
  • ANTIMICROB AGENTS CH 2021 10.1128/AAC.02306-20 In Vitro Activity of Oxazolidinone against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates Kim, DH; Kim, SY; Koh, WJ; Jhun, BW
    View PubMed
  • J GLOB ANTIMICROB RESIST 2021 10.1016/j.jgar.2021.03.006

    Prediction of 1-year treatment outcome using early sputum culture conversion status in Mycobacterium abscessus pulmonary disease

    Park1, YE; Kim, HJ; Jhun, BW; Park, Y; Park, J; Kwak, N; Yim, JJ; Shim, TS; Kang, YA; Jo, KW

    ANTIMICROB AGENTS CH 2021 10.1128/AAC.02611-20

    In Vitro Activity of Rifamycin Derivatives against Nontuberculous Mycobacteria, Including Macrolide- and Amikacin-Resistant Clinical Isolates

    Kim1, DH; Kim, SY; Huh, HJ; Lee, NY; Koh, WJ; Jhun, BW

    CLIN INFECT DIS 2021 10.1093/cid/ciaa1381

    Mortality and Prognostic Factors of Nontuberculous Mycobacterial Infection in Korea: A Population-based Comparative Study

    Lee1, H; Myung, W; Lee, EM; Kim, H; Jhun, BW

    J CLIN MED 2021 10.3390/jcm10071376

    Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Mycobacterium tuberculosis Infections in Tertiary Care Setting?

    Jung1, J; Jhun, BW; Jeong, M; Yoon, SJ; Huh, HJ; Jung, CW; Kim, K; Park, JB; Kim, DJ; Huh, W; Jang, HR; Kim, YH; Hong, SN; Chung, DR; Kang, ES

    SCI REP-UK 2021 10.1038/s41598-021-85721-5

    Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates

    Kim1, SY; Kim, DH; Moon, SM; Song, JY; Huh, HJ; Lee, NY; Shin, SJ; Koh, WJ; Jhun, BW

    YONSEI MED J 2021 10.3349/ymj.2021.62.3.224

    Genetic Analysis of Korean Adult Patients with Nontuberculous Mycobacteria Suspected of Primary Ciliary Dyskinesia Using Whole Exome Sequencing

    Cho1, EH; Ki, CS; Yun, SA; Kim, SY; Jhun, BW; Koh, WJ; Huh, HJ; Lee, NY

    EXP MOL MED 2021 10.1038/s12276-020-00552-0

    MiR-144-3p is associated with pathological inflammation in patients infected with Mycobacteroides abscessus

    Kim1, HJ; Kim, IS; Lee, SG; Kim, YJ; Silwal, P; Kim, JY; Kim, JK; Seo, W; Chung, C; Cho, HK; Huh, HJ; Shim, SC; Park, C; Jhun, BW; Jo, EK

    AM J RESP CRIT CARE 2021 10.1164/rccm.202004-1418OC

    BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease

    Kim1, HJ; Kwak, N; Hong, H; Kang, N; Im, Y; Jhun, BW; Yim, JJ

    FRONT MICROBIOL 2021 10.3389/fmicb.2020.626216

    A Clofazimine-Containing Regimen Confers Improved Treatment Outcomes in Macrophages and in a Murine Model of Chronic Progressive Pulmonary Infection Caused by the Mycobacterium avium Complex

    Lee1, JM; Park, J; Choi, S; Jhun, BW; Kim, SY; Jo, KW; Hong, JJ; Kim, LH; Shin, SJ

    J CLIN MED 2020 10.3390/jcm9092968

    Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease

    Kim1, BG; Kim, H; Kwon, OJ; Huh, HJ; Lee, NY; Baek, SY; Sohn, I; Jhun, BW

    YONSEI MED J 2020 10.3349/ymj.2020.61.8.670

    Clinical Usefulness of Fungal Culture of EBUS-TBNA Needle Rinse Fluid and Core Tissue

    Ko1, RE; Jeong, BH; Huh, HJ; Lee, NY; Yoo, H; Jhun, BW; Han, J; Lee, K; Kim, H; Kwon, OJ; Um, SW

    J CLIN MED 2020 10.3390/jcm9072185

    Clinical Characteristics and Treatment Outcomes of Pathologically ConfirmedAspergillusNodules

    Kang1, N; Park, J; Jhun, BW

    J CLIN MED 2020 10.3390/jcm9051331

    Characteristics of Circulating CD4(+) T Cell Subsets in Patients with Mycobacterium avium Complex Pulmonary Disease

    Han1, SA; Ko, Y; Shin, SJ; Jhun, BW

    CLIN MICROBIOL INFEC 2020 10.1016/j.cmi.2019.10.012

    Early cidofovir administration might be associated with a lower probability of respiratory failure in treating human adenovirus pneumonia: a retrospective cohort study

    Ko1, JH; Lim, JU; Choi, JY; Oh, HS; Yoo, H; Jhun, BW; Huh, K; Peck, KR

    ANN LAB MED 2020 10.3343/alm.2020.40.2.169

    Diagnostic Performance of the GENEDIA MTB/NTM Detection Kit for Detecting Mycobacterium tuberculosis and Nontuberculous Mycobacteria With Sputum Specimens

    Shin1, S; Yoo, IY; Shim, HJ; Kang, OK; Jhun, BW; Koh, WJ; Huh, HJ; Lee, NY

    PLoS One 2020 10.1371/journal.pone.0229299

    Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma

    Lim1, JH; Choi, JY; Im, Y; Yoo, H; Jhun, BW; Jeong, BH; Park, HY; Lee, K; Kim, H; Kwon, OJ; Han, J; Ahn, MJ; Kim, J; Um, SW

    LUNG CANCER 2020 10.1016/j.lungcan.2019.11.021

    The utility of endosonography for mediastinal staging of non-small cell lung cancer in patients with radiological N0 disease

    Shin1, SH; Jeong, BH; Jhun, BW; Yoo, H; Lee, K; Kim, H; Kwon, OJ; Han, J; Kim, J; Lee, KS; Um, SW

    ANTIMICROB AGENTS CH 2020 10.1128/AAC.01787-19

    Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease

    Moon1, SM; Yoo, IY; Huh, HJ; Lee, NY; Jhun, BW

    EUR RESPIR J 2020 10.1183/13993003.00798-2019

    Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study

    Jhun1, BW; Moon, SM; Jeon, K; Kwon, OJ; Yoo, H; Carriere, KC; Huh, HJ; Lee, NY; Shin, SJ; Daley, CL; Koh, WJ

    RESP MED 2020 10.1016/j.rmed.2019.105853

    Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors

    Im1, Y; Lee, J; Kim, SJ; Koh, WJ; Jhun, BW; Lee, SH

    J CLIN MED 2019 10.3390/jcm8111898

    Clinical Characteristics and Outcomes of Surgically Resected Solitary Pulmonary Nodules Due to Nontuberculous Mycobacterial Infections

    Choi1, Y; Jhun, BW; Kim, J; Huh, HJ; Lee, NY

    EUR RESPIR J 2019 10.1183/13993003.00811-2019

    Final treatment outcomes of delamanid-containing regimens in patients with MDR-/XDR-TB in South Korea

    Mok1, J; Kang, H; Koh, WJ; Jhun, BW; Yim, JJ; Kwak, N; Lee, T; Kang, B; Jeon, D

    ANN LAB MED 2019 10.3343/alm.2019.39.6.596

    First Isolation of Mycobacterium virginiense From a Human Pulmonary Specimen

    Jung1, J; Yoo, IY; Jhun, BW; Koh, WJ; Lee, NY; Huh, HJ

    MEDICINE 2019 10.1097/MD.0000000000016826

    Computed tomographic findings of macrolide-resistant Mycobacterium massiliense pulmonary disease and changes after antibiotic treatment

    Yoon1, HJ; Chung, MJ; Koh, WJ; Jhun, BW; Moon, SM

    INFECT GENET EVOL 2019 10.1016/j.meegid.2018.10.003

    Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases

    Huh1, HJ; Kim, SY; Jhun, BW; Shin, SJ; Koh, WJ

    J CLIN MICROBIOL 2019 10.1128/JCM.00516-19

    GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance

    Huh1, HJ; Kim, SY; Shim, HJ; Kim, DH; Yoo, IY; Kang, OK; Ki, CS; Shin, SY; Jhun, BW; Shin, SJ; Daley, CL; Koh, WJ; Lee, NY

    ANTIMICROB AGENTS CH 2019 10.1128/AAC.e00665-19

    In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates

    Kim1, DH; Jhun, BW; Moon, SM; Kim, SY; Jeon, K; Kwon, OJ; Huh, HJ; Lee, NY; Shin, SJ; Daley, CL; Koh, WJ

    EUR RESPIR J 2019 10.1183/13993003.01991-2018

    Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis

    Kwak1, N; Dalcolmo, MP; Daley, CL; Eather, G; Gayoso, R; Hasegawa, N; Jhun, BW; Koh, WJ; Namkoong, H; Park, J; Thomson, R; van Ingen, J; Zweijpfenning, SMH; Yim, JJ

    ANTIMICROB AGENTS CH 2019 10.1128/AAC.02331-18

    Species Distribution and Macrolide Susceptibility of Mycobacterium fortuitum Complex Clinical Isolates

    Kim1, SY; Moon, SM; Jhun, BW; Kwon, OJ; Huh, HJ; Lee, NY; Lee, SH; Shin, SJ; Kasperbauer, SH; Huitt, GA; Daley, CL; Koh, WJ

    EUR RESPIR J 2019 10.1183/13993003.01636-2018

    Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease

    Moon1, SM; Jhun, BW; Daley, CL; Koh, WJ

    DIAGN MICR INFEC DIS 2019 10.1016/j.diagrnicrobio.2018.10.022

    Genetic mutations in linezolid-resistant Mycobacterium avium complex and Mycobacterium abscessus clinical isolates

    Kim1, SY; Jhun, BW; Moon, SM; Jeon, K; Kwon, OJ; Huh, HJ; Lee, NY; Shin, SJ; Daley, CL; Koh, WJ

    RESP MED 2019 10.1016/j.rmed.2019.03.014

    Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease

    Moon1, SM; Jhun, BW; Baek, SY; Kim, S; Jeon, K; Ko, RE; Shin, SH; Lee, H; Kwon, OJ; Huh, HJ; Ki, CS; Lee, NY; Chung, MJ; Lee, KS; Shin, SJ; Daley, CL; Koh, WJ

    EUR J CLIN MICROBIOL 2019 10.1007/s10096-019-03471-9

    Prolonged shedding of type 55 human adenovirus in immunocompetent adults with adenoviral respiratory infections

    Huh1, K; Kim, I; Jung, J; Lee, JE; Jhun, BW; Gu, SH; Song, DH; Lee, EY; Jeong, HJ; Yoo, H

    RESP MED 2019 10.1016/j.rmed.2019.01.012

    Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease

    Moon1, SM; Choe, J; Jhun, BW; Jeon, K; Kwon, OJ; Huh, HJ; Lee, NY; Daley, CL; Koh, WJ

    EMERG INFECT DIS 2019 10.3201/eid2503.181597

    Epidemiology of Nontuberculous Mycobacterial Infection, South Korea, 2007-2016

    Lee1, H; Myung, W; Koh, WJ; Moon, SM; Jhun, BW

    DIAGN MICR INFEC DIS 2019 10.1016/j.diagmicrobio.2018.08.008

    Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens

    Cho1, EH; Huh, HJ; Song, DJ; Lee, SH; Kim, CK; Shin, SY; Ki, CS; Jhun, BW; Moon, SM; Kwon, OJ; Koh, WJ; Lee, NY

    TRIALS 2019 10.1186/s13063-018-3053-1

    Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial

    Lee1, M; Mok, J; Kim, DK; Shim, TS; Koh, WJ; Jeon, D; Lee, T; Lee, SH; Kim, JS; Park, JS; Lee, JY; Kim, SY; Lee, JH; Jo, KW; Jhun, BW; Kang, YA; Ahn, JH; Kim, CK; Shin, S; Song, T; Shin, SJ; Kim, YR; Ahn, H; Hahn, S; Won, HJ; Jang, JY; Cho, SN; Yim, JJ

    RESP MED 2019 10.1016/j.rmed.2018.12.001

    Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting

    Yoo1, IY; Huh, HJ; Kang, OK; Jhun, BW; Koh, WJ; Lee, NY

    J CLIN MED 2018 10.3390/jcm7120559

    F-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Assessing Treatment Response of Pulmonary Multidrug-Resistant Tuberculosis

    Choi1, JY; Jhun, BW; Hyun, SH; Chung, MJ; Koh, WJ

    AM J RESP CRIT CARE 2018 10.1164/rccm.201802-0321OC

    Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease

    Jhun1, BW; Kim, SY; Moon, SM; Jeon, K; Kwon, OJ; Huh, HJ; Ki, CS; Lee, NY; Shin, SJ; Daley, CL; Koh, WJ

    ANTIMICROB AGENTS CH 2018 10.1128/AAC.01105-18

    Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex

    Shin1, SH; Jhun, BW; Kim, SY; Choe, J; Jeon, K; Huh, HJ; Ki, CS; Lee, NY; Shin, SJ; Daley, CL; Koh, WJ

    ENVIRON INT 2018 10.1016/j.envint.2018.06.041

    Short- and long-term exposure to ambient air pollution and circulating biomarkers of inflammation in non-smokers: A hospital-based cohort study in South Korea

    Lee1, H; Myung, W; Jeong, BH; Choi, H; Jhun, BW; Kim, H

    YONSEI MED J 2018 10.3349/ymj.2018.59.8.1004

    Bronchiectasis and Recurrent Respiratory Infections with a De Novo STAT1 Gain-of-Function Variant: First Case in Korea

    Huh1, HJ; Jhun, BW; Choi, SR; Kiln, YJ; Yun, SA; Nham, E; Kong, T; Ki, CS; Koh, WJ

    ANTIMICROB AGENTS CH 2018 10.1128/AAC.00527-18

    Mutations in gyrA and gyrB in Moxifloxacin-Resistant Mycobacterium avium Complex and Mycobacterium abscessus Complex Clinical Isolates

    Kim1, SY; Jhun, BW; Moon, SM; Shin, SH; Jeon, K; Kwon, OJ; Yoo, IY; Huh, HJ; Ki, CS; Lee, NY; Shin, SJ; Daley, CL; Suh, GY; Koh, WJ

    SCI REP-UK 2018 10.1038/s41598-018-30967-9

    The utility of delta neutrophil index in differentiation of pulmonary tuberculosis from community acquired pneumonia

    Jhun1, BW; Sim, YS; Shin, TR; Kim, DG

    ANTIMICROB AGENTS CH 2018 10.1128/AAC.00011-18

    Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease

    Jhun1, BW; Yang, B; Moon, SM; Lee, H; Park, HY; Jeon, K; Kwon, OJ; Ahn, J; Moon, IJ; Shin, SJ; Daley, CL; Koh, WJ

    PLoS One 2018 10.1371/journal.pone.0201242

    Comparison of four models predicting the malignancy of pulmonary nodules: A single-center study of Korean adults

    Yang1, B; Jhun, BW; Shin, SH; Jeong, BH; Um, SW; Zo, JI; Lee, HY; Sohn, I; Kim, H; Kwon, OJ; Lee, K

    DIAGN MICR INFEC DIS 2018 10.1016/j.diagmicrobio.2017.12.008

    Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease

    Choi1, H; Jhun, BW; Kim, SY; Kim, DH; Lee, H; Jeon, K; Kwon, OJ; Huh, HJ; Ki, CS; Lee, NY; Shin, SJ; Daley, CL; Koh, WJ

    ANTIMICROB AGENTS CH 2018 10.1128/AAC.01812-17

    Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease

    Jhun1, BW; Moon, SM; Kim, SY; Park, HY; Jeon, K; Kwon, OJ; Huh, HJ; Ki, CS; Lee, NY; Chung, MJ; Lee, KS; Shin, SJ; Daley, CL; Koh, WJ

    J KOREAN MED SCI 2018 10.3346/jkms.2018.33.e65

    Changing Epidemiology of Nontuberculous Mycobacterial Lung Diseases in a Tertiary Referral Hospital in Korea between 2001 and 2015

    Ko1, RE; Moon, SM; Ahn, S; Jhun, BW; Jeon, K; Kwon, OJ; Huh, HJ; Ki, CS; Lee, NY; Koh, WJ

    CLOSE

    Patients' Rights and Responsibilities

    Patients' Rights

    1. Right to receive medical care

    Patients have the right to receive proper care in a safe setting without discrimination nor should their right to care be violated regardless of their gender, age, religion, social status, nationality, language, race, or physical/mental/financial status. Medical teams shall not refuse to provide care without justifiable reason.

    2. Right to be informed and to make an autonomous decision

    Patients have the right to obtain full and complete information from their medical team, to ask questions, and to determine their agreement or refusal concerning: diagnosis, treatment (purpose, plans and methods), outcomes of care (including unanticipated outcomes), discharge plan, participation in medical research studies, organ transplantation/donation, etc. Within ethical boundaries, patients may discontinue or refuse treatment, request that the medical team explain and suggest alternative treatments, and reserve the right to make their own decisions.

    3. Right to confidentiality

    Patients' rights to confidentiality regarding their physical/health status and privacy will not be violated. Patients can expect that all medical records/reports and their personal privacy will be kept confidential unless the patient has given consent or disclosure is permitted by law. To ensure their privacy, patients may be informed that Individuals not directly involved in their care may not be present and that the number of guardians accompanying patients to consultation rooms may be limited.

    4. Right to request consultation and mediation

    In the event of a medical dispute, patients may request consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency).

    5. Right to have values and beliefs respected

    Patients will not be discriminated against because of their culture, religious values, or beliefs, and their rights will not be violated.

    6. Right to receive care in a safe setting

    Patients have the right to receive hospital-provided care where the patient’s medical information is protected and patient safety can be assured. In addition, patients have the right to be protected from possible dangers that can occur in a hospital and to have stability of mind and body.

    Patients' Responsibilities

    1. Responsibility to trust and respect the medical team

    Patients must accurately inform the medical team of their health condition and must trust and respect the medical team's treatment plan. Patients may be responsible for consequences that result from not following instructions.

    2. Responsibility to not use dishonest methods for medical treatment

    Patients must reveal their identity before receiving any medical care and must not use false or dishonest methods, such as seeking medical care under disguised ownership.

    3. Responsibility to abide by all hospital regulations

    Patients are expected to treat all hospital staff and other patients with courtesy and respect; to abide by all hospital rules; and to earnestly fulfill their financial obligation to the hospital. Also, patients and their family members are expected to participate in all safety regulations.